The Introduction
Atrial fibrillation (af, is one of the most common clinical arrhythmia.The incidence of atrial fibrillation increased with increasing age.60-70岁的发病率约为2-4%，70-80岁的发病率为5-6%，而80岁以上的发病率高达8-10%。房颤作为心律失常并不危及生命，但是房颤导致的血管栓塞等并发症，严重影响患者的生活质量和寿命，给家庭和社会带来沉重负担。随着高龄化社会的都来，房颤已成为日益严重的公众健康问题，受到国内外的广泛重视。临床上，根据房颤的持续时间，将自然停止的房颤称为发作性房颤。不能自然停止需要药物或者除颤才能停止的称为持续性房颤，而药物和除颤均不起效的称为慢性（永久性）房颤。房颤治疗相关的药物的信息，主要来源于临床研究，使得其新药开发收到限制。本次直播课程我们邀请到Chengdu university of traditional Chinese medicineThe new teacher cao introduce the latest development of new drug development for us.
The Schedule
Currently We don 't have any scheduled sessions that match your selection, but both please difference us your details below to register your interest and We' ll contact you if a session is scheduled in your region.
The Details
The treatment of atrial fibrillation dilemma and new progress in drug research
This course will start from the treatment of atrial fibrillation dilemma, introduces the latest development of new drug development.
Time to live: on May 15, on Friday (7-8)
An hour live course includes lecturer thematic content sharing and Q&A question and answer session, dry goods.
Guest lecturer
Cao new
Pharmacology, Ph.D., a researcher at the chengdu university of traditional Chinese medicine
Long engaged in cardiac physiology research.2017年毕业于日本东邦大学药理学专业，获医学博士学位，同年进入东邦大学药学院从事博士后工作，主要研究方向为药物安全性评价，运用离体和在体的模型，预测和评估药物导致的心律失常的风险。评价了阿奇霉素，金刚烷胺等导致药物性QT间期延长综合征的风险。并参与开发了用于安全药理学评价的新型动物模型，超小型迷你猪。2018年进入成都中医药大学，主要从事针灸对心血管系统疾病的作用规律及其机制研究。主持中国和日本国自然基金2项，省部级项目1项，校级基金４项。发表SCI文章３０多篇，其中第一作者文章10篇。
Research and application
Cardiovascular research focuses on health and illness during the function of heart and circulatory system.From basic biology research to research for the center with disease, and then to translational research from bench to bedside, cardiovascular research is a multidisciplinary and diversified applications.Whether you are basic and translational research, or somewhere in between, ADInstruments all can provide a series of solutions, accurate and sensitive human cardiovascular measurement.And with the data flow and noninvasive blood pressure, invasive blood pressure and ECG features such as integrated together, our system can be as your experiment research and development - no matter where you are, can ensure high quality results.
Cardiovascular electrophysiology can accurate measurement and analysis of ECG waveform, heart rate variability, arrhythmia, and cardiac action potential waveform form.Whether it is measuring surface or intracardiac electrocardiogram (ecg), or stimulated, pacemaker or only records,LabChartCustomized tools and modules can be easily, powerful data analysis.